Your cat was just diagnosed with diabetes, and your vet handed you a bag of syringes and a vial of insulin. Two weeks later, a friend mentions her diabetic cat is on a pill now, not injections. You’re confused, maybe a little frustrated, and wondering if you’re already behind on the best approach. If this sounds familiar, you’re not imagining things. Something genuinely significant just happened in feline veterinary medicine, and it happened fast.

On April 27, 2026, the American Animal Hospital Association published its first-ever diabetes management guidelines written specifically for cats, separate from dogs, for the first time in the organization’s history. That’s not a minor update to existing paperwork. It’s a formal acknowledgment that cat diabetes is its own disease requiring its own playbook. And the biggest headline from those guidelines is this: for newly diagnosed, otherwise healthy diabetic cats who have never received insulin, oral SGLT2 inhibitor drugs are now the recommended first-line treatment over insulin injections.

That’s a meaningful shift. If your cat was diagnosed even six months ago, their treatment plan may have been built on the previous standard of care.

What SGLT2 Inhibitors Actually Are (and Why Vets Are Excited)

SGLT2 stands for sodium-glucose cotransporter-2. These drugs work by blocking the kidneys from reabsorbing glucose back into the bloodstream, so excess sugar gets excreted in the urine instead of staying in circulation. Two drugs in this class are now approved for cats in the U.S.: bexagliflozin, sold as Bexacat, and velagliflozin, sold as Senvelgo. Both are oral medications, which means once-daily pill or liquid administration instead of twice-daily injections.

I’ve seen firsthand how insulin injections become the biggest barrier to compliance for cat owners. The timing requirements, the storage, the stress of restraining a fractious cat twice a day , it adds up. An oral option that works at least as well for the right patients is genuinely good news. The 2026 AAHA guidelines, as reported by dvm360 in June 2026, position these drugs at the top of the treatment hierarchy for eligible newly diagnosed cats, which is a significant departure from the insulin-first approach that’s been standard for decades.

What most people don’t realize is how much the remission statistics factor into this decision. The guidelines report that roughly 25% of diabetic cats can achieve remission within the first 2-3 months of diagnosis, and over 50% within 6 months. That window matters enormously. Early, aggressive blood sugar control is what gives a cat the best shot at remission, and the AAHA guidelines reflect a growing consensus that SGLT2 inhibitors may support that goal effectively in appropriate candidates.

The Catch: Not Every Cat Qualifies

Recommended Vet-Approved Dog First Aid Kit with Tick Remover

Essential pet emergency kit with first aid guide, slip leash, and medical supplies for home, car, and camping.

Check Price →

Helpful resource: Arm & Hammer Dog Dental Spray — No Brush Needed is a top-rated option for this. (As an Amazon Associate this site earns from qualifying purchases.)

This is the part I really want you to read carefully, because the eligibility criteria are strict and the consequences of getting it wrong are serious.

SGLT2 inhibitors are only for newly diagnosed cats who have never received insulin and who are otherwise stable. The 2026 AAHA guidelines are explicit that cats with any of the following should NOT receive these drugs and should go straight to insulin instead:

ConditionWhy It Disqualifies SGLT2 Use
Vomiting or poor appetiteSuggests underlying illness, risk of instability
Lethargy or cachexia (muscle wasting)Signs of systemic compromise
Advanced chronic kidney disease (IRIS Stage 3+)Kidneys must function for the drug mechanism to work
Hypercalcemia (elevated blood calcium)Increases risk of complications
Prior insulin useDrug is not indicated after insulin exposure

If your cat has any of these, insulin is still the right call. This isn’t a situation where you advocate for the newer drug because it sounds more convenient. A sick cat presenting with diabetic crisis needs insulin and probably hospitalization.

The other safety warning that every owner on these medications needs to know about is euglycemic diabetic ketoacidosis, or EDKA. This is a dangerous form of ketoacidosis that can develop even when blood glucose readings look normal. In regular DKA, high glucose is your alarm bell. With EDKA, the blood sugar can be deceptively normal while the cat is going into crisis. The 2026 AAHA guidelines call for close monitoring of blood beta-hydroxybutyrate (BHB) levels in cats on SGLT2 inhibitors for exactly this reason. If your cat is on Bexacat or Senvelgo and starts vomiting, becomes lethargic, or stops eating, don’t wait and watch. That’s an emergency vet visit, not a “let’s see how the weekend goes” situation.

How Monitoring Is Changing Too

The new guidelines didn’t just update which drugs to use. They also changed how vets should track blood sugar control, and this one is good news for cats everywhere.

In-hospital glucose curves, where your cat spends hours at the clinic getting blood drawn repeatedly to map their glucose response, are no longer recommended in the 2026 guidelines. If you’ve ever watched your cat come home from one of those visits completely wrung out and stress-eating for two days, you already know why this is welcome news. Stress hyperglycemia in cats is real and well-documented, which means those in-hospital numbers were often misleading anyway.

The preferred replacement is continuous glucose monitors, specifically CGMs designed or adapted for home use in cats. The FreeStyle Libre system has been used off-label in cats for a few years now, and at-home CGM data gives a much more accurate picture of how a cat’s glucose is actually behaving in their normal environment. According to the AAHA’s official resource published April 27, 2026, this shift toward home-based CGM monitoring is a core part of the new framework. If your vet is still defaulting to in-clinic curves as the primary monitoring tool, it’s worth a direct conversation about whether home CGM is an option for your cat.

What to Actually Do If Your Cat Is Diabetic Right Now

If your cat was recently diagnosed and you’re already on insulin, don’t stop. Don’t switch anything without a direct conversation with your vet. What you can do is bring up these new guidelines specifically, by name, and ask whether your cat might be a candidate for SGLT2 therapy at their next recheck, or whether there’s a reason insulin is still the better fit. Some vets have already updated their protocols. Others are still catching up with a guideline that’s only a few months old.

If your cat was just diagnosed and hasn’t started treatment yet, ask specifically: “Are they a candidate for Bexacat or Senvelgo under the new 2026 AAHA guidelines?” Your vet should be able to walk through the eligibility criteria with you. If they’re not familiar with the April 2026 update, as noted in the AVMA’s coverage from May 19, 2026, that’s useful information about where to take your follow-up questions.

The remission window is real, and it’s short. The decisions made in the first few months of a feline diabetes diagnosis genuinely affect whether your cat has a chance at coming off treatment entirely. That’s not pressure to panic. It’s a reason to be an engaged, informed participant in your cat’s care right now.

The good news underneath all of this is that feline diabetes management has more options and more precision than it did even two years ago. A cat diagnosed in 2026 has better tools available than one diagnosed in 2022. That’s worth something, even if navigating a rapidly changing standard of care feels like a lot to take in on top of everything else a new diabetes diagnosis involves.

Sources

This article is for general informational purposes only and does not constitute veterinary advice. Pet health symptoms can have many causes and require professional evaluation. Always consult a licensed veterinarian for diagnosis and treatment specific to your pet.

Disclosure: As an Amazon Associate, we earn a small commission from qualifying purchases at no extra cost to you. We only recommend products that genuinely support the topics covered in this article.